Health Care & Life Sciences » Pharmaceuticals | Shenzhen Neptunus Bioengineering Co. Ltd.

Shenzhen Neptunus Bioengineering Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
229
84
518
499
821
693
Depreciation, Depletion & Amortization
75
99
94
83
118
164
Other Funds
469
687
728
2,890
1,260
997
Funds from Operations
479
381
517
760
1,326
1,741
Changes in Working Capital
598
494
419
2,257
3,756
2,876
Net Operating Cash Flow
119
113
99
1,497
2,430
1,135
Capital Expenditures
286
237
170
283
271
Sale of Fixed Assets & Businesses
139
59
285
263
312
Purchase/Sale of Investments
41
99
196
432
258
Net Investing Cash Flow
195
278
97
629
1,285
Cash Dividends Paid - Total
-
-
-
-
185
Issuance/Reduction of Debt, Net
121
524
38
547
5,290
Net Financing Cash Flow
590
163
690
2,343
3,844
Net Change in Cash
276
228
691
217
129
Free Cash Flow
405
349
72
1,780
2,701
Deferred Taxes & Investment Tax Credit
15
6
4
34
4
113
Net Assets from Acquisitions
6
1
15
229
1,122
Other Sources
-
-
-
52
53

About Shenzhen Neptunus Bioengineering Co.

View Profile
Address
24/F, Haiwang Yinhe Technology Bldg
Shenzhen Guangdong 518057
China
Employees -
Website http://www.neptunus.com
Updated 07/08/2019
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production and distribution of pharmaceutical products. Its products include chemical pharmaceuticals, biological pharmaceuticals, antibiotics, narcotic drugs, biochemical drugs and other traditional Chinese medicines and herbs. The company was founded in 1989 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.